Surprising Fatty Liver Results Could Put Madrigal in Big Pharma’s Sights

[ad_1] Markets Heard on the Street Better-than-expected trial results for company’s NASH treatment could rekindle interest in this disease area [ad_2] Source link

WSJ News Exclusive | Amgen in Advanced Talks to Buy Horizon Therapeutics

[ad_1] WSJ News Exclusive Business U.S. biotechnology company was the last of three suitors standing in an auction for Horizon [ad_2] Source link

The Biotech Takeout Menu Gets Pricier

[ad_1] Markets Heard on the Street Biotech investments are typically risky, but companies regarded as natural takeover targets for big pharma are outperforming [ad_2] Source link